The Use of Empagliflozin and Dulaglutide Improves Metabolic and Glycemia Outcomes in a Real-World Primary Care Setting

Spiliotis I., Gallen IW.

DOI

10.2337/db20-1113-P

Type

Conference paper

Publication Date

2020

Volume

69

Permalink Original publication